Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German doctors approve reimbursement catalogue:

This article was originally published in Clinica

Executive Summary

Proposals for the new German reimbursement catalogue for the office-based doctors sector has gained the universal approval of doctors associations around the country. The catalogue, known as the EBM 2000plus, was presented last week in Berlin by the federal association of statutory health insurance physicians. It must now be put before the evaluation committee of the federal committee of doctors and sickness funds in two months time. The difficulty, said the KBV's principal chairman, Manfred Richter-Reichhelm, will be to get the backing of the sickness funds. "If we cannot agree at the evaluation committee stage, then we will not shy away from further debate at the extended evaluation committee stage," he said. The EBM 2000plus should be in place either by October 1 2003, or January 1 2004 if an early agreement cannot be made.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT068014

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel